ABC | Volume 110, Nº2, Fevereiro 2018

Artigo Original Soeiro et al TSH versus SCA Arq Bras Cardiol. 2018; 110(2):113-118 1. Satar S, Seydaoglu G, Avci A, Sebe A, KarciogluO, Topal M. Prognostic value of thyroid hormone levels in acute myocardial infarction: just an epiphenomenon? Am Heart Hosp J. 2005;3(4):227-33. doi: 10.1111/j.1541-9215.2005.04653.x. 2. Stamate CS, Andronescu AM, Nechita AC, Delcea C, Mihu EM, Vintila MM. Physiopathological aspects of the subclinical alterations of thyroid function associated with acute coronary syndromes. J Med Life. 2013;6(4):409-13. PMID: 24868251. 3. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725-35.doi:10.1161/CIRCULATIONAHA.106.678326. Erratum in: Circulation. 2008;117(3):e18. 4. Hamm CW, Bassand J, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart J. 2011;32(23):2999-3054. doi: 10.1093/eurheartj/ehr236. 5. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA FocusedUpdate of the Guideline for theManagement of PatientsWith Unstable Angina/Non ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012;126(7):875-910. doi: 10.1161/CIR.0b013e318256f1e0. 6. Mehran R, Rao SV, Bahht DL, Gibson M, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials. a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736-47. doi: 10.1161/ CIRCULATIONAHA.110.009449. 7. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358(9285):861-5. doi: 10.1016/S0140- 6736(01)06067-6. 8. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033-41. doi: 10.1001/jama.295.9.1033. 9. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind placebo-controlled trial. Atherosclerosis. 2003;166(2):379-86. doi: 10.1016/S0021-9150(02)00372-6. 10. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidismand the risk of coronary heart disease: ameta-analysis. AmJMed. 2006;119(7):541-51. doi: 10.1016/j.amjmed.2005.09.028. 11. Abdulaziz Qari F. Thyroid hormone profile in patients with acute coronary syndrome. Iran Red Crescent Med J. 2015;17(7):e26919. doi: 10.5812/ircmj.26919v2. 12. KleinI,OjamaaK.Thyroidhormoneandthecardiovascularsystem.NEngl J Med. 2001;344(7):501-9. doi: 10.1056/NEJM200102153440707. 13. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab. 2002;87(3):968-74. doi: 10.1210/jcem.87.3.8302. 14. Collet TH, Gussekloo J, Bauer DC, den ElzenWP, Cappola AR, Balmer P, et al; Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799-809. doi: 10.1001/archinternmed.2012.402. 15. Napoli R, Biondi B, Guardasole V, MatarazzoM, Pardo F, Angelini V, et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation. 2001;104(25):3076-80. doi: https://doi. org/10.1161/hc5001.100621. 16. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270-8. doi: 10.7326/0003-4819-132-4-200002150-00004. 17. Forfar JC, Muir AL, Sawyers SA, Toft AD. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. NEngl J Med. 1982;307(19):1165-70. doi: 10.1056/ NEJM198211043071901. 18. Walsh JP, Bremner AP, Bulsara MK, O’Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165(21):2467-72. doi: 10.1001/ archinte.165.21.2467. 19. Kim DH, Choi DH, Kim HW, Choi SW, Kim BB, Chung JW, et al. Prediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction. Korean J Intern Med. 2014;29(4):454-65. doi: 10.3904/kjim.2014.29.4.454. 20. Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acutemyocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med. 2002;162(12):1388-94. doi:10.1001/archinte.162.12.1388. 21. Lymvaios I,Mourouzis I, Cokkinos DV, DimopoulosMA, Toumanidis ST, Pantos C. Thyroid hormone and recovery of cardiac function in patients with acutemyocardial infarction: a strong association? Eur J Endocrinol. 2011;165(1):107-14. doi: 10.1530/EJE-11-0062. 22. Zhang M, Sara JD, Matsuzawa Y, Gharib H, Bell MR, Gulati R, et al. Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention. Eur Heart J. 2016;37(26):2055- 65. doi: 10.1093/eurheartj/ehv737. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 118